T

TEVA

Teva Pharm

17.00

-0.09-0.53%
After Hours: 16.90  -0.10  -0.58%19:56 06/25 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

39.33B

43.48B

44.01B

47.67B

50.64B

Total Current Assets

12.55B

12.49B

12.05B

12.57B

13.01B

Total Non Current Assets

26.77B

30.99B

31.96B

35.09B

37.63B

Total Liabilities

33.61B

35.35B

35.41B

36.42B

39.58B

Total Current Liabilities

12.80B

12.25B

11.47B

11.03B

13.16B

Total Non Current Liabilities

20.81B

23.11B

23.94B

25.39B

26.41B

Total Equity

5.72B

8.13B

8.60B

11.24B

11.06B

Total Stockholders Equity

5.37B

7.51B

7.80B

10.28B

10.03B

Minority Interest

347.00M

620.00M

794.00M

966.00M

1.03B

Total Liabilities & Shareholders Equity

39.33B

43.48B

44.01B

47.67B

50.64B

Total Common Shares Outstanding

1.13B

1.12B

1.12B

1.10B

1.10B

Total Preferred Shares Outstanding

--

--

--

--

0